![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SS Lazio SPA | BIT:SSL | Italy | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.006 | 0.81% | 0.746 | 0.734 | 0.746 | 0.746 | 0.734 | 0.736 | 1,088 | 12:32:47 |
RNS Number:1572R SSL International PLC 22 October 2003 22 October 2003 Trading update for the Half Year Ended 30th September 2003 Sales for the six months to 30th September 2003 are likely to be in the region of #316 million and are expected to generate a pre-exceptional operating margin in excess of 10%. Sales in the comparative period of #308 million generated a margin of 10%. Branded consumer sales are expected to be approximately #188 million, being some 5% ahead of the same period last year largely as the result of strong underlying growth in Durex and positive Euro/GBP exchange rate movements. Underlying Scholl sales are expected to be broadly in line with last year, as growth in Europe has been offset by the effects of poor economic conditions in the Asia Pacific region in the first quarter. As previously indicated, OTC sales in Italy have continued to be affected by pharmacy de-stocking. Medical sales of approximately #92 million are expected to be 2% ahead of last year as underlying growth of 5% in Biogel gloves was offset by negative US$/GBP exchange rate movements and a decline of approximately #1 million in sales of our wound management products. The outlook for the full year remains in line with our expectations. Disposal Programme The disposal programme is on track. Negotiations for the disposal of the industrial gloves business are well advanced and we expect to make an announcement very shortly. As previously indicated, we have received interest from a substantial number of parties for the disposal of our medical division. We are now in discussions with a short list of interested parties. Further announcements will be made in due course. END For further information, please contact: SSL International plc 020 7367 5760 Garry Watts, Group Finance Director Jan Young, Head of Investor Relations The Maitland Consultancy 020 7379 5151 William Clutterbuck Brian Hudspith This information is provided by RNS The company news service from the London Stock Exchange END TSTGGMZGRMZGFZM
1 Year SS Lazio Chart |
1 Month SS Lazio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions